Q3 2024 update: ecommerce related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that ecommerce accounted for eight pharmaceutical deals announced in Q3 2024,…
MA
-
-
Q2 2024 update: M&A activity in pharmaceutical in Sweden
In the Swedish pharmaceutical industry, there were 9 M&A deals announced in Q2 2024, worth a total value of $1bn,…
-
Q1 2024 update: personalization related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that personalization accounted for 2 pharmaceutical deals announced in Q1 2024,…
-
Q1 2024 update: individualism & expression related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that individualism & expression accounted for 2 pharmaceutical deals announced in…
-
How immuno-oncology M&A performed in the pharmaceutical industry in Q3 2024
Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 18 pharmaceutical deals announced in Q3 2024,…
-
Q2 2024 update: energy transition related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that energy transition accounted for 5 pharmaceutical deals announced in Q2…
-
Q3 2024 update: cloud related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that cloud accounted for two pharmaceutical deals announced in Q3 2024,…
-
Q4 2023 update: renewable energy related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that renewable energy accounted for 2 pharmaceutical deals announced in Q4…
-
Q4 2023 update: easy & affordable related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that easy & affordable accounted for 3 pharmaceutical deals announced in…
-
Q4 2023 update: remote patient monitoring related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that remote patient monitoring accounted for 3 pharmaceutical deals announced in…